Haemonetics (HAE) Price to Sales (2009 - 2026)

Haemonetics has reported Price to Sales for 18 years, with the latest figure at 10.36 in Q2 2026.

• On a quarterly basis, Price to Sales fell 6.36% year-over-year to 10.36 in Q2 2026; TTM through Jun 2026 was 2.6, a 1.55% decrease from a year earlier, with the FY2026 full-year figure at 1.83, down 18.12% from the prior year.
• Price to Sales was 10.36 for Q2 2026 at Haemonetics, up from 7.06 in the prior quarter.
• The five-year high for Price to Sales was 14.29 in Q3 2023, with the low at 6.88 in Q3 2025.
• Average Price to Sales over 5 years is 11.58, with a median of 12.32 recorded in 2022.
• The largest YoY upside for Price to Sales was 24.52% in 2022 against a maximum downside of 58.43% in 2022.
• Over 5 years, Price to Sales stood at 13.0 in 2022, then declined by 0.62% to 12.91 in 2023, then slipped by 13.43% to 11.18 in 2024, then dropped by 0.8% to 11.09 in 2025, then decreased by 6.63% to 10.36 in 2026.
• The last three Price to Sales figures came in at 10.36 (Q2 2026), 7.06 (Q1 2026), and 11.09 (Q4 2025), per Business Quant data.